![Mark Charest](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Charest
Chief Executive Officer at
Phenomic Capital LLC
Profile
Mark Geoffrey Charest is the founder of Phenomic Capital LLC, serving as Portfolio Manager since 2017.
Former jobs include Director at Itero Biopharmaceuticals, Inc., Associate at Great Point Partners LLC, Senior Vice President of Research at Tekla Capital Management LLC, Principal at ZS Associates, Inc. in 2009, Portfolio Manager at New Leaf Venture Partners LLC from 2012 to 2015, Associate at Panorama Capital LLC from 2010 to 2012, Medicinal Chemistry Lab Manager at Novartis Institutes for Biomedical Research, Inc. from 2004 to 2007, and Venture Partner at LifeSci Venture Partners.
Founding Partner & Portfolio Manager at LifeSci Fund Management LLC from 2019 to 2024.
Education includes a doctorate from Harvard University and an undergraduate degree from Rutgers State University of New Jersey.
Mark Charest active positions
| Companies | Position | Start |
|---|---|---|
Phenomic Capital LLC
 Phenomic Capital LLC Investment ManagersFinance Provides investment advice | Chief Executive Officer | 2016-12-31 |
Former positions of Mark Charest
| Companies | Position | End |
|---|---|---|
LifeSci Fund Management LLC
 LifeSci Fund Management LLC Investment ManagersFinance LFM’s Fund aims to achieve long-term capital appreciation. The Fund focuses on disruptive life sciences innovators, robust cash flow/revenue growth companies, and direct funding through private placements, IPOs, and other structured transactions. | Founder | 2024-10-31 |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Private Equity Analyst | 2015-01-30 |
LifeSci Venture Partners
 LifeSci Venture Partners Investment ManagersFinance LifeSci Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical, technology, life sciences and healthcare sector. It provides financing for early and later stage capital requirements. | Private Equity Investor | - |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Analyst-Equity | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Training of Mark Charest
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Great Point Partners LLC
 Great Point Partners LLC Investment ManagersFinance Great Point seeks to achieve positive excess returns by investing in publicly traded biotechnology, pharmaceutical and life science companies. The firm focuses on creating a balanced portfolio comprised primarily of companies that are undervalued by the public markets. Their hedge funds employ a bottom-up research-driven approach to investing in the securities of undervalued, publicly-traded healthcare companies. Great Point Partners targets fast-growing, technology- driven small-cap companies. In addition, the firm manages private equity funds that invest in private, primarily profitable, lower middle-market, growing healthcare companies. | Finance |
Itero Biopharmaceuticals, Inc.
 Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for novel therapeutic proteins and antibodies | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tekla Capital Management LLC
Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
ZS Associates, Inc.
 ZS Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting and technology firm | Commercial Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Panorama Capital LLC
 Panorama Capital LLC Investment ManagersFinance Panorama Capital invests in companies located in the United states. The firm targets companies operating in the fields of life sciences, internet infrastructure & services and semiconductors. It provides financing for seed, early and later stage capital requirements with an investment size ranging from USD 5 - 20 million. | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
LifeSci Venture Partners
LifeSci Venture Partners Investment ManagersFinance LifeSci Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical, technology, life sciences and healthcare sector. It provides financing for early and later stage capital requirements. | Finance |
LifeSci Fund Management LLC
LifeSci Fund Management LLC Investment ManagersFinance LFM’s Fund aims to achieve long-term capital appreciation. The Fund focuses on disruptive life sciences innovators, robust cash flow/revenue growth companies, and direct funding through private placements, IPOs, and other structured transactions. | Finance |
Phenomic Capital LLC
Phenomic Capital LLC Investment ManagersFinance Provides investment advice | Finance |
- Stock Market
- Insiders
- Mark Charest
